SignatureFD’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $79.1K | Sell |
527
-258
| -33% | -$28.1K | ﹤0.01% | 1587 |
|
|
2026
Q1 | $72.5K | Sell |
785
-4
| -0.5% | -$402 | ﹤0.01% | 1509 |
|
|
2025
Q4 | $80.6K | Sell |
789
-112
| -12% | -$10K | ﹤0.01% | 1411 |
|
|
2025
Q3 | $56.3K | Buy |
901
+266
| +42% | +$14.5K | ﹤0.01% | 1574 |
|
|
2025
Q2 | $33K | Buy |
635
+213
| +50% | +$9.51K | ﹤0.01% | 1811 |
|
|
2025
Q1 | $18K | Sell |
422
-341
| -45% | -$14.7K | ﹤0.01% | 2111 |
|
|
2024
Q4 | $23.3K | Buy |
763
+39
| +5% | +$1.1K | ﹤0.01% | 1988 |
|
|
2024
Q3 | $16.6K | Buy |
724
+344
| +91% | +$9.74K | ﹤0.01% | 2124 |
|
|
2024
Q2 | $11K | Buy |
380
+206
| +118% | +$4.8K | ﹤0.01% | 2226 |
|
|
2024
Q1 | $3.59K | Sell |
174
-38
| -18% | -$815 | ﹤0.01% | 2650 |
|
|
2023
Q4 | $5.74K | Sell |
212
-291
| -58% | -$7.63K | ﹤0.01% | 2460 |
|
|
2023
Q3 | $14.9K | Buy |
503
+46
| +10% | +$1.62K | ﹤0.01% | 2006 |
|
|
2023
Q2 | $16.4K | Buy |
457
+342
| +297% | +$9.82K | ﹤0.01% | 1987 |
|
|
2023
Q1 | $2.7K | Sell |
115
-283
| -71% | -$8.08K | ﹤0.01% | 2716 |
|
|
2022
Q4 | $10.8K | Buy |
398
+14
| +4% | +$641 | ﹤0.01% | 2110 |
|
|
2022
Q3 | $21K | Buy |
384
+79
| +26% | +$4.06K | ﹤0.01% | 1705 |
|
|
2022
Q2 | $12K | Sell |
305
-33
| -10% | -$1.64K | ﹤0.01% | 2030 |
|
|
2022
Q1 | $22K | Buy |
338
+88
| +35% | +$6.02K | ﹤0.01% | 1789 |
|
|
2021
Q4 | $25K | Sell |
250
-119
| -32% | -$12.3K | ﹤0.01% | 1694 |
|
|
2021
Q3 | $46K | Buy |
369
+130
| +54% | +$15.4K | ﹤0.01% | 1349 |
|
|
2021
Q2 | $30K | Buy |
239
+60
| +34% | +$8.07K | ﹤0.01% | 1540 |
|
|
2021
Q1 | $27K | Buy |
179
+6
| +3% | +$907 | ﹤0.01% | 1445 |
|
|
2020
Q4 | $22K | Sell |
173
-15
| -8% | -$1.73K | ﹤0.01% | 1420 |
|
|
2020
Q3 | $21K | Sell |
188
-81
| -30% | -$7.41K | ﹤0.01% | 1349 |
|
|
2020
Q2 | $22K | Buy |
269
+19
| +8% | +$1.53K | ﹤0.01% | 1301 |
|
|
2020
Q1 | $17K | Buy |
250
+164
| +191% | +$12.6K | ﹤0.01% | 1294 |
|
|
2019
Q4 | $7K | Sell |
86
-1
| -1% | -$72 | ﹤0.01% | 1557 |
|
|
2019
Q3 | $6K | Hold |
87
| – | – | ﹤0.01% | 1563 |
|
|
2019
Q2 | $8K | Buy |
87
+1
| +1% | +$76 | ﹤0.01% | 1465 |
|
|
2019
Q1 | $7K | Buy |
+86
| New | +$4.77K | ﹤0.01% | 1505 |
|
Other funds holding GH
DTC
SignatureFD's GH Position: Q2 2026 in Review
SignatureFD reduced its Guardant Health (GH) stake by 33% in Q2 2026, selling an estimated $28.1K and leaving 527 shares worth $79.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1587.
SignatureFD first reported a position in GH in Q1 2019 and has held it in 30 quarters since. The position peaked at $80.6K in Q4 2025. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- SignatureFD held 527 shares of Guardant Health worth $79.1K as of Q2 2026.
- SignatureFD sold 258 Guardant Health shares in Q2 2026, an estimated $28.1K.
- Guardant Health made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #1587 holding.
- SignatureFD first reported a position in Guardant Health in Q1 2019 and has held it in 30 quarters since.
- SignatureFD's Guardant Health position peaked at $80.6K in Q4 2025.
- 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.